Showing 7021-7030 of 20410 results for "".
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
https://reachmd.com/programs/cme/her2-breast-cancer-with-brain-metastases-rethinking-first-line-treatment-in-the-adc-era/56518/Apply clinical evidence and multidisciplinary strategies to select and sequence systemic and local therapies for brain metastases in breast and lung cancer.Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
https://reachmd.com/programs/cme/sequencing-systemic-and-local-therapy-in-her2-overexpressing-metastatic-nsclc/56520/Apply clinical evidence and multidisciplinary strategies to select and sequence systemic and local therapies for brain metastases in breast and lung cancer.EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
https://reachmd.com/programs/cme/egfr-mutated-nsclc-with-brain-metastases-navigating-adc-treatment-decisions/56521/Apply clinical evidence and multidisciplinary strategies to select and sequence systemic and local therapies for brain metastases in breast and lung cancer.Managing Brain Metastases Through Multidisciplinary Team Collaboration
https://reachmd.com/programs/cme/managing-brain-metastases-through-multidisciplinary-team-collaboration/56522/Apply clinical evidence and multidisciplinary strategies to select and sequence systemic and local therapies for brain metastases in breast and lung cancer.First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
https://reachmd.com/programs/cme/first-line-management-of-hrher2-low-breast-cancer-with-brain-metastases/56519/Apply clinical evidence and multidisciplinary strategies to select and sequence systemic and local therapies for brain metastases in breast and lung cancer.Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
https://reachmd.com/programs/cme/special-report-management-considerations-and-unmet-needs-in-lgs-and-dravet-syndrome/15112/Find out how you can manage polypharmacy in Lennox-Gastaut syndrome and Dravet syndrome and learn what new therapies are on the horizon.Advances in the Management of Difficult-to-Treat Asthma
https://reachmd.com/programs/cme/advances-in-the-management-of-difficult-to-treat-asthma/10893/This multidisciplinary, virtual roundtable brings together clinicians and a patient to discuss clinical aspects of care in people with asthma.Phyto A+ Brightening Treatment for Skin Brightening, Texture, and Clarity, Suitable for Sensitive Skin
https://reachmd.com/ma-supplements/2022-jan-feb-insert/phyto-a-brightening-treatment-for-skin-brightening-texture-and-clarity-suitable-for-sensitive-skin/35139/Weekly Check-up | April 4th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-april-4th-2016/8037/Welcome to the Weekly Check-up on ReachMD for the week of April 4th, 2016.The Cell Death Pathway: Leveraging Glioblastoma Treatments
https://reachmd.com/programs/neurofrontiers/the-cell-death-pathway-leveraging-glioblastoma-treatments/15111/What role does nutrition have in treating patients with glioblastoma? Tune in for details on a new cell death pathway that could potentially treat tumor cells.